Wave Life Sciences

Read more
Paul Bolno's photo - President & CEO of Wave Life Sciences

President & CEO

Paul Bolno

CEO Approval Rating

87/100

Founded:

2012

Status:

PublicIndependent CompanyNASDAQWVE

WAVE LIFE SCIENCES TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Wave Life Sciences's company profile
Paul Bolno's photo - President & CEO of Wave Life Sciences

Paul Bolno

President & CEO

87/100
250
$227.8M
$15.7M
View Profile
1
Wave Life Sciences's Competitor - Alnylam logo
John Maraganore's photo - CEO of Alnylam

John Maraganore

CEO

100/100
1,065
$2.5B
$687.5M
View Profile
2
Wave Life Sciences's Competitor - Axolabs logo
Roland Kreutzer's photo - Managing Director of Axolabs

Roland Kreutzer

Managing Director

70/100
62
- -
$5M
View Profile
3
Wave Life Sciences's Competitor - Voyager logo
Michael Higgins's photo - Interim-CEO of Voyager

Michael Higgins

Interim-CEO

83/100
123
$267.1M
$132.2M
View Profile
4
Wave Life Sciences's Competitor - Arrowhead logo
Christopher Anzalone's photo - President & CEO of Arrowhead

Christopher Anzalone

President & CEO

78/100
134
- -
$107.6M
View Profile
5
Wave Life Sciences's Competitor - Regulus logo
Joseph P. Hagan's photo - President & CEO of Regulus

Joseph P. Hagan

President & CEO

84/100
24
$210.9M
$10M
View Profile
6
Wave Life Sciences's Competitor - Amunix logo
Angie You's photo - CEO of Amunix

Angie You

CEO

86/100
50
$230M
$1.2M
View Profile
7
Wave Life Sciences's Competitor - Lumena Pharmaceuticals logo
CEO Avatar

CEO

- -
134
$45M
$29.2M
View Profile
8
Wave Life Sciences's Competitor - Triplet Therapeutics logo
Nessan Bermingham's photo - President & CEO of Triplet Therapeutics

Nessan Bermingham

President & CEO

90/100
200
$59M
$3.5M
View Profile
9
Wave Life Sciences's Competitor - Ra Pharma logo
CEO Avatar

CEO

- -
89
$48.2M
$3M
View Profile
10
Wave Life Sciences's Competitor - Guided Therapeutics logo
Gene Cartwright's photo - CEO of Guided Therapeutics

Gene Cartwright

CEO

68/100
9
$26.8M
$ < 1M
View Profile
11
Wave Life Sciences's Competitor - Genentech logo
Alexander Hardy's photo - CEO of Genentech

Alexander Hardy

CEO

76/100
13,638
$2B
$18.3B
View Profile
12
Wave Life Sciences's Competitor - Pharming logo
Sijmen De Vries's photo - Chairman & CEO of Pharming

Sijmen De Vries

Chairman & CEO

82/100
229
$117M
$216.8M
View Profile

Missing a competitor? Contribute!

Alnylam is one of Wave Life Sciences's top rivals. Alnylam's headquarters is in Cambridge, Massachusetts, and was founded in 2002. Like Wave Life Sciences, Alnylam also competes in the Biotechnology industry. Alnylam generates 4,388% of Wave Life Sciences's revenue.

Axolabs has been one of Wave Life Sciences's top competitors. Axolabs was founded in 2000 in Kulmbach, Bavaria. Like Wave Life Sciences, Axolabs also operates in the Biotechnology field. Axolabs generates $10.7M less revenue than Wave Life Sciences.

Voyager is one of Wave Life Sciences's top competitors. Voyager was founded in Cambridge, Massachusetts} in 2014. Like Wave Life Sciences, Voyager also competes in the Biotechnology sector. Compared to Wave Life Sciences, Voyager generates $116.6M more revenue.

Wave Life Sciences Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$15.7M

Wave Life Sciences's revenue is the ranked lowest among it's top 10 competitors. The top 10 competitors average 1.3B. Over the last three quarters, Wave Life Sciences's revenue has decreased by 19.5%. Specifically, in Q2 2021's revenue was $2.8M; in Q4 2020, it was $9.4M; in Q3 2020, it was $3.5M.

Wave Life Sciences Acquisitions

No recent acquisitions found related to Wave Life Sciences

Wave Life Sciences Funding History

Since Wave Life Sciences was founded in 2012, it has participated in 5 rounds of funding. In total Wave Life Sciences has raised $227.8M. Wave Life Sciences' last funding round was on Dec 2015 for a total of $30.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Nov 2015
$102M
-
Series B
Aug 2015
$66M
Series A
Feb 2015
$18M
Equity
Jan 2015
$11.8M
-

Since Wave Life Sciences was founded in 2012, it has participated in 5 rounds of funding. In total Wave Life Sciences has raised $227.8M. Wave Life Sciences' last funding round was on Dec 2015 for a total of $30.0M

Wave Life Sciences Investments

No recent investments found related to Wave Life Sciences

Wave Life Sciences News

September 28, 2021MarketScreener

Wave Life Sciences Announces New Data for Leading RNA Editing Capability Across Multiple Tissues and Provides Update on AATD Program During Analyst and Investor Research Webcast

(marketscreener.com) Durable ADAR editing in vivo in preclinical models, including in CNS tissues wit... See more »
September 22, 2021MarketScreener

Wave Life Sciences to Present at the Chardan Virtual Genetic Medicines Conference

(marketscreener.com) CAMBRIDGE, Mass., Sept. 22, 2021 -- Wave Life Sciences Ltd. , a clinical-stage g... See more »
September 9, 2021MarketScreener

Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a SELECT-HD Clinical Trial of WVE-003 in Huntington's Disease

(marketscreener.com) Only clinical-stage candidate for Huntington's disease designed to selectively l... See more »
September 7, 2021MarketScreener

Wave Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

(marketscreener.com) CAMBRIDGE, Mass., Sept. 07, 2021 -- Wave Life Sciences Ltd. , a clinical-stage g... See more »
August 16, 2021MarketScreener

Submission of Matters to a Vote of Security Holders (Form 8-K)

(marketscreener.com) - Shareholders re-electednine of the Company's existing directors to the Board o... See more »

Wave Life Sciences Press Releases

May 14, 2021StreetInsider

WVE) Featured in Mizuho Securities Research Report

Wave Life Sciences (NASDAQ: WVE) was...... See more »
January 11, 2021GlobalNewswire

Wave Life Sciences Highlights Pipeline Progress and Expansion Leveraging New PN Backbone Chemistry Modifications

Three clinical trials to begin in 2021 with compounds containing Wave's novel PN backbone chemistry m... See more »
November 10, 2020GlobeNewswire

Wave Life Sciences to Present at the 29th Annual Credit Suisse Healthcare Conference

CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical... See more »
September 23, 2020GlobeNewswire

Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares

CAMBRIDGE, Mass., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinica... See more »
April 29, 2020GlobeNewswire

Wave Life Sciences to Webcast Conference Call of First Quarter 2020 Financial Results on May 11, 2020

CAMBRIDGE, Mass., April 29, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinica... See more »
November 5, 2019GlobeNewswire

Wave Life Sciences Reports Third Quarter 2019 Financial Results and Provides Business Update

Fast Track designation for suvodirsen received from the U.S. FDA... See more »
July 29, 2019GlobeNewswire

Wave Life Sciences Reports Second Quarter 2019 Financial Results and Provides Business Update

Interim efficacy data from ongoing suvodirsen open-label extension study on track for 4Q 2019... See more »

Social Media

Wave Life Sciences Headquarters

733 Concord Avenue

Cambridge, Massachusetts02138

1-617-949-2900

Driving Directions »

Trending Companies

Wave Life Sciences Summary

ABOUT

Overview

Wave Life Sciences develops next-generation nucleic acid drugs that achieve high systemic bioavailability. Wave Life Sciences was founded in 2012. Wave Life Sciences' headquarters is located in Cambridge, Massachusetts, USA 02138. Wave Life Sciences'...

CEO

Wave Life Sciences's President & CEO, Paul Bolno, currently has an approval rating of 87%. Wave Life Sciences's primary competitors are Alnylam, Axolabs & Voyager.

Frequently Asked Questions about Wave Life Sciences

  1. When was Wave Life Sciences founded?

    Wave Life Sciences was founded in 2012
  2. Who is Wave Life Sciences's CEO?

    Wave Life Sciences's CEO is Paul Bolno
  3. How much revenue does Wave Life Sciences generate?

    Wave Life Sciences generates $15.7M in revenue
  4. How much funding does Wave Life Sciences have?

    Wave Life Sciences has historically raised $227.8M in funding
  1. Where is Wave Life Sciences's headquarters?

    Wave Life Sciences's headquarters is in Cambridge Massachusetts, USA
  2. How many employees does Wave Life Sciences have?

    Wave Life Sciences has 250 employees
  3. What sector does Wave Life Sciences operate in?

    Wave Life Sciences is in Biotechnology, Pharmaceuticals
  4. Who are Wave Life Sciences's competitors?

    Wave Life Sciences's top competitors are Alnylam, Axolabs, Voyager